Turner Financial Group Inc. Buys New Stake in ARK Genomic Revolution ETF $ARKG

Turner Financial Group Inc. purchased a new position in shares of ARK Genomic Revolution ETF (BATS:ARKG) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 38,834 shares of the company’s stock, valued at approximately $1,633,000. ARK Genomic Revolution ETF makes up about 1.6% of Turner Financial Group Inc.’s holdings, making the stock its 12th largest holding. Turner Financial Group Inc. owned 0.09% of ARK Genomic Revolution ETF as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently added to or reduced their stakes in the company. Ascentis Independent Advisors purchased a new position in ARK Genomic Revolution ETF in the first quarter valued at $26,000. PNC Financial Services Group Inc. raised its position in shares of ARK Genomic Revolution ETF by 53.2% in the first quarter. PNC Financial Services Group Inc. now owns 1,088 shares of the company’s stock worth $29,000 after acquiring an additional 378 shares during the period. Sunbelt Securities Inc. boosted its stake in shares of ARK Genomic Revolution ETF by 734.3% during the 3rd quarter. Sunbelt Securities Inc. now owns 1,118 shares of the company’s stock worth $31,000 after acquiring an additional 984 shares in the last quarter. Western Wealth Management LLC purchased a new stake in shares of ARK Genomic Revolution ETF during the 1st quarter worth about $37,000. Finally, Strategic Wealth Investment Group LLC acquired a new stake in shares of ARK Genomic Revolution ETF during the 2nd quarter valued at about $38,000.

ARK Genomic Revolution ETF Stock Performance

Shares of ARK Genomic Revolution ETF stock opened at $47.14 on Friday. ARK Genomic Revolution ETF has a twelve month low of $24.60 and a twelve month high of $50.53. The business has a 50-day moving average price of $43.03 and a 200 day moving average price of $34.74.

ARK Genomic Revolution ETF Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.